Evidence map›Paper›PMID 38205769›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2023

Green synthesized silver nanoparticles for the treatment of diabetes and the related complications of hyperlipidemia and oxidative stress in diabetic rats.

Yousra G El-Baz, Amr Moustafa, Mohamed A Ali, Gaber E El-Desoky, Saikh M Wabaidur, Amjad Iqbal

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic Efficacy ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Therapeutic potential of silver nanoparticles fromFrontiers in bioengineering and biotechnology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Yousra G El-BazBiochemistry Department, Faculty of Agriculture, Cairo University, Giza 12613, Egypt.
Amr MoustafaBiochemistry Department, Faculty of Agriculture, Cairo University, Giza 12613, Egypt.
Mohamed A AliBiochemistry Department, Faculty of Agriculture, Cairo University, Giza 12613, Egypt.ORCID 0000-0002-1717-8265
Gaber E El-DesokyChemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Saikh M WabaidurChemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-3858-5556
Amjad IqbalFaculty of Chemistry, Gdańsk University of Technology, Gdańsk 80-233, Poland.
Cairo University · EGKing Saud University · SAGdańsk University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was conducted to compare the impact of cinnamon silver nanoparticles (C-Ag-NPs) and cinnamon aqueous extract (CAE) on the total body weight (TBW), body weight gain (BWG), blood count (BC), fasting blood glucose (FBG), triglycerides (TGs), total cholesterol (TC), low-density (LDL-C) and high-density (HDL-C) lipoprotein cholesterol, liver function enzymes, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) of normal and streptozotocin (STZ) diabetic rats. The CAE was administered to rats at different doses (50.0 and 100.0 mg/kg bw), whereas the C-Ag-NPs were ingested at doses of 25.0 and 50.0 mg/kg bw for 30 days. At the end of the experiment, the administration of high or low dosages of CAE or C-Ag-NPs to diabetic rats significantly reduced the FBG, TC, TG, and LDL-C and significantly increased the HDL-C compared with the diabetic control rats. The highest dose (50.0 mg/kg bw) of the C-Ag-NPs was the most efficient at significantly reducing (

Indexed as

Diabetes Mellitus, ExperimentalHyperlipidemiasMetal NanoparticlesAnimalsAntioxidantsBlood GlucoseBody WeightCholesterol, LDLOxidative StressPlant ExtractsRatsRats, WistarSilverSuperoxide DismutaseAntioxidantsBlood GlucoseCholesterol, LDLPlant ExtractsSilverSuperoxide DismutaseantioxidantchronicCinnamon barkdiabetic controlextractnanoparticles

Identifiers

PMID38205769
PMCPMC10903233
OpenAlexW4390744238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.